2m 2m 2m 2m 2m 2m 2m
Immucell (ICCC)
NASDAQ
$10.64+$0.42 (+4.07%)
Price as of Nov 13, 2026 1:35 PM EST- $92.8MMarket Cap
- 68.93%1-Year Change
- BiotechnologyIndustry
Immucell (ICCC)
$10.64+$0.42 (+4.07%)
ICCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.22 | ||
Change | +$0.03 (+0.29%) | ||
Open | $10.21 | ||
High | $10.32 | ||
Low | $10.20 | ||
Previous Close | $10.19 | ||
Volume | 19,304 | ||
30-Day Average Volume | 7,996 | ||
1-Week Change | 2.71% | ||
1-Month Change | 6.46% | ||
1-Year Change | 68.93% | ||
3-Year Change | 89.26% | ||
5-Year Change | 10.81% | ||
Fundamentals | |||
Shares Outstanding | 9.1M | ||
Total Assets | $48.0M | ||
Market Cap | $92.8M | ||
Enterprise Value | $92.8M | ||
Period: QTR TTM FY | |||
Revenue | $8.0M | ||
Net Income | $100,000.00 | ||
Free Cash Flow | -$589,355.00 | ||
EBIT | $82,765.00 | ||
EBITDA | $82,765.00 | ||
Net Working Capital | $16.9M | ||
EPS | $0.10 | ||
Enterprise Value/EBITDA | 1,121 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | 102 | ||
PEG | -2 | ||
Price/Free Cash Flow | -157 | ||
Price/Operating Cash Flow | 123 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue